Amgen (NASDAQ:AMGN) today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha® (evolocumab) achieved statistically significant and clinically meaningful ...
Rosemarie D. Hoenisch With heavy hearts, we announce the passing of Rosemarie Dolores Hoenisch, a beloved mother, sister, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback